Vicarious Trauma: Preventing, Recognizing Its Effects in Oncology Clinicians
A review of how vicarious trauma develops in helping professionals such as oncology nurses, and some preventive measures to mitigate its effects.
A review of how vicarious trauma develops in helping professionals such as oncology nurses, and some preventive measures to mitigate its effects.
Researchers sought to determine whether ruxolitinib would improve clinical outcomes in patients with treatment-resistant PV.
Childhood cancer survivors have a higher risk of requiring surgical interventions up to 35 years after diagnosis, a large study suggests.
Randomized trial compared effects of ginger oil, peppermint oil, and canola oil on CINV in patients receiving chemotherapy prior to bone marrow transplantation.
Changes to primary endpoints of phase 3 cancer trials may be common and underreported, a study suggests.
Declines seen in current smoking, physical inactivity, heavy alcohol consumption; increase seen in uptake of HPV vaccine, stool testing for CRC.
The probability that a cancer drug would receive FDA approval within 10 years of entering trials was 10.4%, researchers found.
The prospective, multicenter NEOetic study explored relationships between patient prognostic awareness and decisions regarding treatment.
In a study of 16,870 oncologists practicing in the United States, 21% left patient-facing roles between 2015 and 2022.
Pediatric cancer patients who develop MIS-C after COVID-19 have a worse clinical course than patients without MIS-C, a study suggests.